Gasporox: Weak quarter, strong order book - Redeye

Redeye states that the Q4 report was weaker than expected with net sales coming in 43% lower than expected and EBITDA 98% lower than expected. However, we believe most of the miss is due to high expectations on Q4 in particular while results are becoming more even over the year. We still believe the long-term story is intact and expect to raise H1'23 estimates while lower the Q4'23 estimates. We expect no to slight reduction in our Base Case.

Länk till analysen i sin helhet: https://www.redeye.se/research/882379/gasporox-weak-quarter-strong-order-book?utm_source=finwire&utm_medium=RSS